[Laboratory diagnosis in inflammatory bowel disease]

Area of Science:

• Gastroenterology
• Clinical Biochemistry
• Immunology

Background:

• Inflammatory Bowel Disease (IBD) assessment relies on clinical evaluation and biological markers.
• Monitoring disease activity is crucial for effective IBD management.
• Nutritional deficiencies and infections can complicate IBD diagnosis and treatment.

Purpose of the Study:

• To outline the essential clinical and biological markers for assessing IBD activity.
• To highlight the role of specific markers in monitoring disease progression.
• To emphasize the importance of differentiating IBD subtypes and ruling out infections.

Main Methods:

• Review of established clinical parameters for IBD assessment.
• Analysis of classical and novel biological disease markers (e.g., CRP, leukocyte count).
• Evaluation of nutritional marker determination (e.g., ferritin, vitamin B12) and stool culture utility.
• Assessment of antibody detection (pANCA, ASCA) for differential diagnosis.

Main Results:

• Classical markers like erythrocyte sedimentation rate and C-reactive protein (CRP) are vital for monitoring IBD activity.
• Nutrient level assessment (zinc, iron, vitamin B12, folic acid) is critical for patients with severe disease or post-surgery.
• Stool cultures aid in identifying infections that mimic IBD, and specific antibodies assist in distinguishing Crohn's disease from ulcerative colitis.

Conclusions:

• A comprehensive approach combining clinical, biochemical, and immunological markers is essential for accurate IBD assessment.
• Regular monitoring of disease activity and nutritional status optimizes patient outcomes.
• Diagnostic tools like antibody testing and stool cultures are indispensable for precise diagnosis and management of IBD.